The creatinine excretion (CrEx) ratio was first described as a method for d
etecting noncompliance in peritoneal dialysis (PD) patients. However, a hig
h CrEx ratio is not specific for noncompliance and may also be found in com
pliant patients with a relatively greater lean body mass (LBM). A cohort of
44 PD patients was followed up for a mean of 13 +/- 8 months after measure
ment of baseline CrEx ratio to investigate whether greater values were pred
ictive of good or poor clinical outcomes. During this follow-up, 11 patient
s died, 12 patients transferred to hemodialysis, 4 patients underwent trans
plantation, 1 patient recovered renal function, and 16 patients continued o
n PD. The mean CrEx ratio in all patients was 1.14 +/- 0.32. It did not dif
fer between men and women (1.15 versus 1.13, respectively; P = 0.76) but sh
owed a trend toward being less in patients with diabetes (1.03 versus 1.19;
P = 0.19). The mean weekly Kt/V, weekly creatinine clearance, normalized p
rotein equivalent of nitrogen appearance, and serum albumin values were 2.1
8 +/- 0.57, 73.57 +/- 33.75 L/1.73 m(2), 0.80 +/- 0.22 g/kg/d, and 3.22 +/-
0.59 g/dL, respectively. Technique failure (P < 0.001) and death (P < 0.05
) were significantly more common in patients with a CrEx ratio less than 1
compared with those with a CrEx ratio greater than 1. On Cox regression ana
lysis, the CrEx ratio was the only significant predictor of technique failu
re and was also an independent predictor of death. High CrEx ratio is a pre
dictor of good, rather than poor, outcome in PD patients, perhaps because i
t is primarily an index of nutrition. This further weakens the argument tha
t it is a reliable or useful marker of noncompliance. (C) 2000 by the Natio
nal Kidney Foundation, Inc.